Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51
Authors:
- Enric XipellEXEnric Xipell
- Tomás AragónTATomás Aragón
- Naiara Martínez-VelezNMNaiara Martínez-Velez
- Beatriz VeraBVBeatriz Vera
- Miguel Angel IdoateMiguel Angel Idoate
- Juan José Martínez-IrujoJMJuan José Martínez-Irujo
- Antonia García GarzónAGAntonia García Garzón
- Marisol Gonzalez-HuarrizMGMarisol Gonzalez-Huarriz
- Arlet M. AcandaAAArlet M. Acanda
- Chris JonesCJChris Jones
- Frederick F. LangFLFrederick F. Lang
- Juan FueyoJFJuan Fueyo
Open Access
- 6 March 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 18 (8) , 1109-1119
Abstract
Endoplasmic reticulum (ER) stress results from protein misfolding imbalance and has been postulated as a therapeutic strategy. ER stress activates the unfolded protein response which leads to a complex cellular response, including the upregulation of aberrant protein degradation in the ER, with the goal of resolving that stress. O6-methylguanine DNA methyltransferase (MGMT), N-methylpurine DNA glycosylase (MPG), and Rad51 are DNA damage repair proteins that mediate resistance to temozolomide in glioblastoma. In this work we sought to evaluate whether ER stress-inducing drugs were able to downmodulate DNA damage repair proteins and become candidates to combine with temozolomide. MTT assays were performed to evaluate the cytotoxicity of the treatments. The expression of proteins was evaluated using western blot and immunofluorescence. In vivo studies were performed using 2 orthotopic glioblastoma models in nude mice to evaluate the efficacy of the treatments. All statistical tests were 2-sided. Treatment of glioblastoma cells with ER stress-inducing drugs leads to downregulation of MGMT, MPG, and Rad51. Inhibition of ER stress through pharmacological treatment resulted in rescue of MGMT, MPG, and Rad51 protein levels. Moreover, treatment of glioblastoma cells with salinomycin, an ER stress-inducing drug, and temozolomide resulted in enhanced DNA damage and a synergistic antitumor effect in vitro. Of importance, treatment with salinomycin/temozolomide resulted in a significant antiglioma effect in 2 aggressive orthotopic intracranial brain tumor models. These findings provide a strong rationale for combining temozolomide with ER stress-inducing drugs as an alternative therapeutic strategy for glioblastoma.Keywords
Funding Information
- European Commission
- Spanish Ministry of Health
- Ministerio de Ciencia e Innovación
- CajaNavarra Foundation
This publication has 44 references indexed in Scilit:
- The impact of the endoplasmic reticulum protein-folding environment on cancer developmentNature Reviews Cancer, 2014
- Endoplasmic Reticulum Stress and the Unfolded Protein Response: Targeting the Achilles Heel of Multiple MyelomaMolecular Cancer Therapeutics, 2013
- Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma CellsPLOS ONE, 2012
- Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cellsNeuro-Oncology, 2011
- Measuring ER Stress and the Unfolded Protein Response Using Mammalian Tissue Culture System2011
- Association of elevated GRP78 expression with increased astrocytoma malignancy via Akt and ERK pathwaysBrain Research, 2011
- GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosisNeuro-Oncology, 2008
- P-Glycoprotein Limits Oral Availability, Brain Penetration, and Toxicity of an Anionic Drug, the Antibiotic SalinomycinAntimicrobial Agents and Chemotherapy, 2008
- That which does not kill me makes me stronger: adapting to chronic ER stressTrends in Biochemical Sciences, 2007
- Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.2000